The NGS sample preparation market is witnessing an uptick owing to factors such as favorable government initiatives, increasing public-private investments in the field of next-generation sequencing, and the rising cancer incidences. For instance, in America, nearly 1.9 million new cancer cases was expected to be diagnosed in 2021. Approximately 608,570 Americans are expected to die of cancer in...